Christopher Smith’s Article on the Drug Supply Chain Security Act Featured in Bloomberg Roundup: “For Your Consideration”Bloomberg BNA Daily Labor Report August 3, 2019
Christopher R. Smith, Senior Counsel in the Health Care & Life Sciences and Litigation & Business Disputes practices, in the firm’s Washington, DC, office, authored an article titled “INSIGHT: The Drug Supply Chain Security Act and Preemption of State Laws” that was featured in the Bloomberg BNA Daily Labor Report roundup of articles “For Your Consideration,” by Robert Wilhelm. (Read the full version – subscription required.)
Following is an excerpt:
Every week, Bloomberg Law features articles written by and for legal practitioners, offering an insider’s view into the most important issues across every practice area: Bloomberg Law Insights. …
For Your Consideration
The Drug Supply Chain Security Act and Preemption of State Laws
Preemption of state laws by the federal Drug Supply Chain Security Act has arisen multiple times since the act’s passage, a response to counterfeit drugs entering the U.S. supply chain. Epstein Becker Green’s Christopher R. Smith takes a closer look at the act’s two preemption provisions and the challenges involved.